Patent · US Active

Modified MGLUR6 promoter and methods of use

US10307492B2 · kind B2 · utility

1Cited by
2References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 11, 2015
Grant dateJun 4, 2019
Priority date
Expiry dateMar 11, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/42
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides nucleic acids and nucleic acid expression vectors containing optimized mGluR6 promoters for expression of transgenes in the retina. The compositions and methods of the invention are useful for expression of gene products to preserve, improve, or restore phototransduction or vision.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.